Clinical trial Recruiting at 1 site Interventional Ages 4 to 10

Treatment targeting anterior pelvic tilt and soleus weakness in children with cerebral palsy and crouch gait

Official title: Physical Therapy Protocol for Crouch Gait Associated to the Anterior Pelvic Tilt and Soleus Muscle Weakness in CP Patient

Run by Philadelphia University, Jordan · NCT07147933 · Data updated 2026-11-12

This will try a focused physical therapy program to strengthen the soleus muscle and correct anterior pelvic tilt to improve crouch gait in walking children with cerebral palsy aged 4 to 10.

More Cerebral Palsy (CP) trials

Quick facts

Study typeInterventional
Ages4 Years to 10 Years
SexAll
Enrollment40 (estimated)
SponsorPhiladelphia University, Jordan
Academic / other
Locations1 site (Amman)
StatusRecruiting
StartedJuly 2, 2025
Main results expectedMarch 2, 2026
Study endsMarch 2, 2026
Registry record updatedJanuary 9, 2026
Trial IDNCT07147933 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are ambulatory children with cerebral palsy aged 4–10 who have crouch gait, measurable anterior pelvic tilt, and soleus weakness on EMG, with BMI between 18.5 and 21 and no history of selective dorsal rhizotomy.

Probably not a fit

Children who are non-ambulatory, have posterior pelvic tilt, a history of selective dorsal rhizotomy, are outside the 4–10 age range, or whose BMI is outside 18.5–21 are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional program enrolls ambulatory children aged 4–10 with cerebral palsy who present with crouch gait, anterior pelvic tilt, and soleus weakness confirmed by EMG. Participants undergo a structured physical therapy program emphasizing soleus strengthening and exercises to improve pelvic alignment. Muscle function and gait changes are monitored with EMG and clinical gait observation over the treatment period. Children with prior selective dorsal rhizotomy, posterior pelvic tilt, non-ambulatory status, or BMI/age outside the protocol ranges are excluded.

Why it matters

Potential benefit: If successful, the program could improve walking posture and function and reduce the need for more invasive interventions in children with crouch gait.

How similar studies have gone: Prior research has typically targeted hamstring stretching and quadriceps strengthening with only partial correction of crouch gait, and targeting the soleus and pelvic tilt is a relatively novel approach with limited published evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

patient with cp have a crouch gait. ages from 4 to 10 years . have a anterior pelvic tilt . muscle weakness (Soleus) on EMG.

* BMI from 18.5 to 21..
* didn't submit to Selective Dorsal Rhizotomy surgery.

Exclusion Criteria:

have a posterior pelvic tilt.

-above 10 or below 4 years. not able to walk. . submitted to SDR surgery. BMI above 21 or below 18.5.

Where it's running

  • Queen Rania AL Abdullah hospital for children
    Amman, Jordan
    Recruiting

Study contacts

  • Principal investigator: Ahmed Yasser Mostafa Marouf, bachelor's physical thrapy — Bachelor's of Physical Therapy, Faculty of Allied Medical Sciences, Philadelphia University, Amman
  • Study coordinator: Ahmed Yasser Mostafa Marouf, bachelor's physical thrapy
  • Email: ahmedmarouf00@icloud.com
  • Phone: +201026913232

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.